Pascal Brandys: A Trailblazing Journey in Biotech and Entrepreneurship
Biography of Pascal Brandys:
Pascal Brandys, born on November 30, 1958, in Roanne,
France, is a distinguished engineer and entrepreneur. He holds a degree from
the prestigious École Polytechnique and earned his M.S. in Economic Systems
from Stanford University in 1982.
Pascal Brandys: Pioneering Biotech Ventures
Pascal Brandys started his career in investing money in
startup companies, first in Japan and then in the UK, where he helped kickstart
the early days of biotech firms in Europe.
Leading Genset and France Biotech
He founded Genset Corporation and led it to become a top
player in genomics in Europe, making it one of the biggest biotech companies on
the continent. He also co-founded and ran France Biotech, a group representing
biotech businesses in France.
Pascal Brandys: A Trailblazing Journey in Biotech and Entrepreneurship / Biography of Pascal Brandys
Biobank and Phylex BioSciences
In 2001, he co-founded Biobank, a company focusing on
biotech investments in San Diego. Then, in 2020, he started Phylex BioSciences,
aiming to create a vaccine for COVID-19. In 2022, the vaccine showed Phylex
BioSciences: Pioneering a Universal SARS Vaccine
Phylex BioSciences, founded by genomics pioneer Pascal
Brandys and coronavirus specialist Jens Herold at the onset of the SARS-CoV-2
pandemic, is leading the charge in developing a universal vaccine against the SARS
coronavirus.
The vaccine, a culmination of antigen engineering with
conserved epitopes and cutting-edge VLP (virus-like particle) technology, aims
to provide protection not only against SARS-CoV-2 but also against future
virulent strains of the SARS coronavirus.promising results in tests.
Extensive Experience in Biotech and Finance
From 2013 to 2019, Brandys served as the co-founder and CEO
of CompuVax, a company recognized for its expertise in computational
engineering of vaccines. Prior to this, he held leadership roles at Biobank
Technology Ventures LLC and served as Chairman and CEO of Genset, a genomics
company he co-founded in 1989. Under his leadership, Genset grew to a market
capitalization exceeding $1.5 billion before its acquisition by Merck-Serono in
2002.
Pascal Brandys: Leading Phylex BioSciences
Pascal Brandys holds the positions of co-founder, Chairman,
and CEO at Phylex BioSciences, where the focus is on developing a universal
vaccine for SARS coronavirus. With over 30 years of experience in the
biotechnology industry and global finance, Brandys has a deep understanding of
both sectors.
Successes in Leadership and Corporate Governance
Brandys's career includes significant involvement in
corporate governance, with directorships in notable public and private
companies such as NASDAQ listed Innogenetics NV, ILOG SA, and Ceres, Inc. His
early career saw him as a pioneer in biotechnology investments in Europe and
Japan, holding key positions at Unihon Services in Tokyo and Eurocontinental
Ventures in London during the 1980s.
Recognition in the Industry
For his significant contributions to biotech, Brandys
received the Outstanding Service to Biotechnology Award at a European life
sciences conference in Amsterdam in 1999.
Pascal Brandys: Entrepreneurship and Corporate Leadership
Pascal Brandys has a track record of founding successful
ventures in the biotech sector, including France Biotech Association, Biobank
Technology Ventures, and Phylex Biosciences, Inc.
Currently, Brandys serves as a Director at Anima Biotech,
Inc., leveraging his expertise to contribute to the company's growth and
strategic direction.
Previously, he held directorship positions at ILOG SA and
Fujirebio Europe NV, where he played key roles in guiding these companies
towards success.
Additionally, Brandys served as an Independent Director at
Ceres, Inc. (California), providing valuable insights and oversight from 2012
to 2016.
